1. Home
  2. CCO vs GHRS Comparison

CCO vs GHRS Comparison

Compare CCO & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCO
  • GHRS
  • Stock Information
  • Founded
  • CCO 1995
  • GHRS 2018
  • Country
  • CCO United States
  • GHRS Ireland
  • Employees
  • CCO N/A
  • GHRS N/A
  • Industry
  • CCO Advertising
  • GHRS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCO Consumer Discretionary
  • GHRS Health Care
  • Exchange
  • CCO Nasdaq
  • GHRS Nasdaq
  • Market Cap
  • CCO 899.6M
  • GHRS 774.1M
  • IPO Year
  • CCO 2005
  • GHRS 2021
  • Fundamental
  • Price
  • CCO $1.80
  • GHRS $13.53
  • Analyst Decision
  • CCO Hold
  • GHRS Strong Buy
  • Analyst Count
  • CCO 5
  • GHRS 9
  • Target Price
  • CCO $2.13
  • GHRS $29.33
  • AVG Volume (30 Days)
  • CCO 4.4M
  • GHRS 274.3K
  • Earning Date
  • CCO 11-06-2025
  • GHRS 11-07-2025
  • Dividend Yield
  • CCO N/A
  • GHRS N/A
  • EPS Growth
  • CCO N/A
  • GHRS N/A
  • EPS
  • CCO 0.04
  • GHRS N/A
  • Revenue
  • CCO $1,538,895,000.00
  • GHRS N/A
  • Revenue This Year
  • CCO $6.16
  • GHRS N/A
  • Revenue Next Year
  • CCO $4.01
  • GHRS N/A
  • P/E Ratio
  • CCO $40.92
  • GHRS N/A
  • Revenue Growth
  • CCO 31.61
  • GHRS N/A
  • 52 Week Low
  • CCO $0.81
  • GHRS $6.72
  • 52 Week High
  • CCO $2.03
  • GHRS $20.50
  • Technical
  • Relative Strength Index (RSI)
  • CCO 57.52
  • GHRS 50.01
  • Support Level
  • CCO $1.75
  • GHRS $12.50
  • Resistance Level
  • CCO $2.03
  • GHRS $14.44
  • Average True Range (ATR)
  • CCO 0.12
  • GHRS 1.04
  • MACD
  • CCO -0.00
  • GHRS 0.01
  • Stochastic Oscillator
  • CCO 64.71
  • GHRS 45.24

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: